Global Ambulatory Surgical Center Software Market Seeks Prosperous Horizon: Projecting 10% Growth by 2027

 

A need to contain growing healthcare costs; Some of the key factors driving growth in the ambulatory surgical center software market are the growing trend of performing surgical procedures in ambulatory settings, which has resulted in an increase in the number of procedures at ASCs; increasing physician and patient preference for outpatient surgeries; and the launch of advanced solutions for ASCs.

Ambulatory care is a medical care provided in outpatient setting and does not require hospital admission. Ambulatory Surgical Center or ASCs — are health care facilities specialized in providing same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by providing a more convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs include cataract surgery, gallbladder removal, tonsillectomy, endoscopy/colonoscopy, arthroscopic/orthopedic procedures, and cardiac procedures. Because of their cost benefits and convenience the volume of procedures performed at ASCs is Increasing and software are likely to play a crucial role in these settings by easing day to day operations by effectively preparing staff and patients for pre-op and post-op tasks.

Increasing investment in ASC space from healthcare companies/PEs indicates the high growth potential in the Ambulatory Surgical Center Software Market

Investment firms have recognized the increasing popularity of undergoing surgeries in non-hospital environments, as well as the importance of Ambulatory Surgery Centers (ASCs) in facilitating these procedures. Drawn by the lucrative growth potential in the space, many investors have backed independent ASCs and have consolidated to form larger groups/chains. United Surgical Partners International (USPI), AmSurg, HCA, and Surgical Care Affiliates (now SCA Health) are some of the examples of large ASC chains operating in the U.S. Number of ASCs operated by USPI have increased from ~250 in 2015 to more than 465 at present. Similarly, number of facilities operated by Surgical Care Affiliates increased from about 185 in 2015 to more than 320.

Major Companies are focusing on development of new solutions for ASCs

Key players in the Ambulatory Surgical Center Software Market are constantly concentrating on developing new software solutions or adding new features to existing ASC solutions. Some of the related developments are listed below-

· In January 2023, Ospitek launched live patient charting for ambulatory surgery centres (ASCs) as part of the company’s latest update to the proprietary surgical coordination platform “VIEW”

· In November 2022, 3M Health Information Systems (HIS) announced the launch of 3M Ambulatory Potentially Preventable Complications (3M AM-PPCs) software, developed to ensure patient safety and quality oversight for procedures performed at ASCs/hospital outpatient departments

· In October 2022, EClincalWorks launched EHR software, V12. The new version has features such as 40% faster speeds, improved usability with redesigned screens, a module for pre visit planning, Improved procedure documentation, and enhancements to the ASC workflow model, among others

ASCs are not federally mandated to implement EHRs — a barrier to the adoption of ASC solutions in the U.S can Hamper the Ambulatory Surgical Center Software Market

Since 2008, EHR adoption in office-based settings has been increasing by over 100% from ~40% to more than 80%. However, according to the Ambulatory Surgery Center Association (ASCA), the adoption rate of EHRs in ASC settings remains low (approx. only 20%). Larger adoption rate in non-ASC settings is due to the Health Information Technology for Economic and Clinical Health (HITECH) Act (2009). This act authorized financial incentives of billions of dollars for doctors and hospitals for EHR implementation and Imposed a reimbursement penalty for those providers not using a certified EHR. But, it is not compulsory for ASCs to implement EHRs which has caused their low adoption in these settings. However, low adoption rate also indicates that there is an ample scope for ASC solution providers to penetrate the Ambulatory Surgical Center Software market.

North America Holds a Dominant share in the ambulatory surgical center software market

From a geographical outlook, North America holds a large market share of the ambulatory surgical center software market. This is mainly attributed to the presence of large number of ASC centers and number of procedures being performed, relatively greater adoption of ASC solutions, rising financial incentives, and high prevalence of various diseases and associated surgeries. The number of Medicare certified ASCs have shown consistent growth in the U.S. from ~5200 in 2011 to ~5500 in 2015 and ~5800 in 2020 (total number of ASCs in the U.S. is ~11,800). In the past, procedures performed at ASCs were reimbursed based on the Consumer Price Index for All Urban Consumers (“CPI-U”), which resulted in lower reimbursement rates for these procedures.However, from 2019 through 2023, CMS decided to update the ASC payment system using the hospital market basket update, rather than the CPI-U. This further improved reimbursement for ASC procedures. Such developments are likely to drive ASC and in turn, ASC software market growth.

Competitive landscape Analysis of the Ambulatory Surgical Center software market

Some of the key players in Ambulatory Surgical Center software market includes athenahealth, Cerner, Epic, Allscripts, Surgical Information Systems (SIS), HST Pathways, EClincalWorks, Nextgen Healthcare, and Advanced Data Systems Corporation, among others.

Get Detailed Insights on the Ambulatory Surgical Center software market @ https://meditechinsights.com/ambulatory-surgical-center-software-market/

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global 3D Cell Culture Market Seeks Prosperous Horizon: Double-Digit Growth Expected by 2027

Image
  The need for organ transplants and tissue engineering combined with developments in scaffold-free technology, a rise in investments and research and development (R&D) funding for cell-based studies, growing efforts to develop potential alternatives to animal-based testing, and the rising incidence of chronic diseases are some of the major factors propelling the growth of the global 3D cell culture market. 3D cell culture   is an important approach in cell biology and tissue engineering because it includes cultivating and analyzing cells in a three-dimensional environment that mimics the circumstances present in the human body. It has several advantages, such as the capacity to recreate in vivo settings, allow the creation of complex multicellular structures, and give realistic drug testing situations. Scaffold-based technologies employing materials such as hydrogels are employed for 3D cell culturing. Its uses include cancer research, tissue engineering, and medication d...
Read more

Global Tricuspid Valve Repair Market Driven by Innovation: Set to Surge with a US$2.5 Billion Market by 2028

Image
  Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcatheter tricuspid valve repair (TTVR), increased clinical research and trials activities for developing new tricuspid valve repair technologies, and rising incidence of tricuspid valve disorders are some of the key factors driving the global tricuspid valve repair market. • Medical technology advancements in the field of cardiac interventions. • Improved awareness of heart valve disorders. One of the four valves in our heart that regulates blood flow is the tricuspid valve . It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close. Tricuspid valve illnesses are disorders that some people have that impair the tricuspid valve's a...
Read more